Skip to main content
Teva logo Pharmaceutical Industries Ltd.
  • Teva Worldwide
  • Stock
  • Contact Us
  • Hebrew
  • Toggle search

See Teva's sites around the world

North America

  • Canada Canada
  • United States United States

International Markets

  • Argentina Argentina
  • Australia Australia
  • Belarus Belarus
  • Brazil Brazil
  • Chile Chile
  • China China
  • India India
  • Israel Israel
  • Japan Japan
  • Kazakhstan Kazakhstan
  • Mexico Mexico
  • Peru Peru
  • Russia Russia
  • Singapore Singapore
  • South Africa South Africa
  • South Korea South Korea
  • Turkey Turkey
  • Ukraine Ukraine
  • Uruguay Uruguay
  • Uzbekistan Uzbekistan

Europe

  • Europe Europe
  • Austria Austria
  • Belgium Belgium
  • Bosnia & Herzegovina Bosnia & Herzegovina
  • Bulgaria Bulgaria
  • Croatia Croatia
  • Czech Republic Czech Republic
  • Denmark Denmark
  • Estonia Estonia
  • Finland Finland
  • France France
  • Germany Germany
  • Greece Greece
  • Hungary Hungary
  • Ireland Ireland
  • Italy Italy
  • Latvia Latvia
  • Lithuania Lithuania
  • Macedonia Macedonia
  • Netherlands Netherlands
  • Norway Norway
  • Poland Poland
  • Portugal Portugal
  • Romania Romania
  • Serbia Serbia
  • Slovakia Slovakia
  • Slovenia Slovenia
  • Spain Spain
  • Sweden Sweden
  • Switzerland Switzerland
  • United Kingdom United Kingdom
Want to find out more about Teva's locations and phone numbers? Visit Teva Worldwide
Teva logo
  • About
    • Company Profile
    • Corporate Officers
    • Corporate Governance
    • Board of Directors
    • Our History
    2017 Annual Report – Form 10-K
    Quality
    Notice of Annual Meeting of Shareholders 2017 – Proxy Statement
  • Products
    • Specialty
    • Generic Products
    • Generic FAQ
    • Over the Counter (OTC)
    • API
    • Quality
    Central Nervous System (CNS)
    Respiratory
  • Research
    • Our Philosophy
    • Patient Promise
    • Pipeline
    • Clinical Trials
    National Network of Excellence
  • Responsibility
    • Social Impact
    • Positions & Policies
    • Patient Advocacy
    Social Impact Report
    Multiple Chronic Conditions
  • Media
    • Latest News
    • Featured Stories
    • Social Media
    Featured stories
    Social Media
  • Investors
    • Careers
      • Dare to be different
      • Our Guiding Values
      • Leadership Development
      • Working at Teva
      Dare to be different
      Search Teva Jobs
    • Teva Worldwide
    • Contact Us
    • Hebrew
      Follow Us:
    • Toggle search
    • Investors
      • Press Releases
      • Events & Presentations
      • Financial Information
        • Quarterly Results
        • SEC Filings
      • Debt Information
        • Debt Information
        • Quarterly Debt Factsheet
      • Stock Information
        • Stock Quote & Chart
        • Dividends and Stock Splits
        • Key Ratios
        • Analyst Coverage
      • Corporate Governance
      • Investor Resources
        • Financial Tear Sheet
        • ADR Depositary Bank
        • Shareholder Meetings
        • Investor FAQs
        • Investor Kit
        • MCPS Related Documents
        • Email Alerts
        • Contact IR
        • RSS Feeds
    Home  >  Investors  >  Investor Resources  >  Contact IR

    Contact IR

    • Investors
      • Press Releases
      • Events & Presentations
      • Financial Information
        • Quarterly Results
        • SEC Filings
      • Debt Information
        • Debt Information
        • Quarterly Debt Factsheet
      • Stock Information
        • Stock Quote & Chart
        • Dividends and Stock Splits
        • Key Ratios
        • Analyst Coverage
      • Corporate Governance
      • Investor Resources
        • Financial Tear Sheet
        • ADR Depositary Bank
        • Shareholder Meetings
        • Investor FAQs
        • Investor Kit
        • MCPS Related Documents
        • Email Alerts
        • Contact IR
        • RSS Feeds

    Kevin C. Mannix
    SVP, Investor Relations
    Phone: (215) 591-8912
    E-mail: kevin.mannix@tevapharm.com

    Ran Meir
    VP, Investor Relations
    Phone: +972 (3) 926-7516
    E-mail: ran.meir@teva.co.il

    Edward J. Barger
    Sr. Manager, Investor Relations
    Phone: (267) 468-4743
    E-mail: edward.barger@tevapharm.com

    Quick Links

    • Quarterly Results
    • Events and Presentations
    • Investor Resources
    • Corporate Governance

    Email Alerts

    To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

    At Teva Pharmaceutical Industries Ltd, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

    By providing your email address below, you are providing consent to Teva Pharmaceutical Industries Ltd to send you the requested Investor Email Alert updates.

    * Required

    *
    *



     
    Enter the code shown above.

    Email Alert Sign Up Confirmation

    IR Contact

    Contact
    • About
      • Company Profile
      • Corporate Officers
      • Corporate Governance
      • Board of Directors
      • Our History
    • Products
      • Specialty
      • Generic Products
      • Generic FAQ
      • Over the Counter (OTC)
      • API
      • Quality
    • Research
      • Integrated R&D
      • Our Focus
      • Patient Promise
      • Pipeline
    • Responsibility
      • Social Impact
      • Positions & Policies
      • Patient Advocacy
    • Media
      • Latest News
      • Featured Stories
      • Social Media
    • Investors
      • Press Releases
      • Events & Presentations
      • Financial Information
      • Debt Information
      • Stock Information
      • Corporate Governance
      • Investor Resources
    • Careers
      • Dare to be different
      • Our Guiding Values
      • Leadership Development
      • Working at Teva

    Follow Teva:

    • Legal Notes
    • Data Privacy
    • TAPI
    • Teva Supplier Code of Conduct
    • Sitemap
    © Teva Pharmaceutical Industries Ltd.
    Powered By Q4 Inc. 5.15.0.14 (opens in new window)